Compare LXEO & SLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LXEO | SLI |
|---|---|---|
| Founded | 2017 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 663.5M | 595.8M |
| IPO Year | 2023 | N/A |
| Metric | LXEO | SLI |
|---|---|---|
| Price | $9.38 | $4.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $18.22 | $5.25 |
| AVG Volume (30 Days) | 1.2M | ★ 3.6M |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.45 | $1.08 |
| 52 Week High | $10.38 | $6.40 |
| Indicator | LXEO | SLI |
|---|---|---|
| Relative Strength Index (RSI) | 53.99 | 63.89 |
| Support Level | $9.27 | $4.02 |
| Resistance Level | $10.04 | $4.42 |
| Average True Range (ATR) | 0.63 | 0.32 |
| MACD | -0.08 | 0.11 |
| Stochastic Oscillator | 59.94 | 84.56 |
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company is focused on the exploration and development of the Arkansas Lithium Project, which is located in south-central Arkansas. Its other projects comprise the Lanxess Project, and Bristol Dry Lake Project.